Publications by authors named "Cecilia Alvim"

Claim this Profile
N
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.
Federica Lo Prinzi, Francesca Salani, Silvia Camera, Mario Domenico Rizzato, Anna Saborowski, Cecilia Melo Alvim

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.
Chiara Pirrone, Umberto Malapelle, Francesco Pepe, Federica Lo Prinzi, Federico Nichetti, Cecilia Melo Alvim

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population.
Margherita Rimini, Lorenzo Fornaro, Federica Lo Prinzi, Mario Domenico Rizzato, Anna Saborowski, Cecilia Melo Alvim

J Natl Cancer Inst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study.
Margherita Rimini, Lorenzo Fornaro, Federica Lo Prinzi, Mario Domenico Rizzato, Anna Saborowski, Cecilia Melo Alvim

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy.
Francesco Vitiello, Caterina Vivaldi, Mario Domenico Rizzato, Anna Saborowski, Lorenzo Antonuzzo, Cecilia Melo Alvim

Oncology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.
Mara Persano, Margherita Rimini, Francesca Salani, Federica Lo Prinzi, Federico Nichetti, Cecilia Melo Alvim

Liver Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and neck cancer patient journey's health literacy: a multidisciplinary team perspective. VOICE study.
Ana Joaquim, Cláudia Vieira, Leonor Ribeiro, Anabela Barros, Inês Leão, Cecília Alvim

Support Care Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization.
Carolina Peixoto, Marta B Lopes, Marta Martins, Sandra Casimiro, Daniel Sobral, Cecília Alvim

BMC Bioinformatics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy.
Carolina Borges da Ponte, Tito Palmela Leitão, Miguel Miranda, Joana Polido, Cecília Alvim

Urology· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.
Mahdi Golkaram, Michael L Salmans, Shannon Kaplan, Raakhee Vijayaraghavan, Marta Martins, Cecília Alvim

NPJ Genom Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for patients treated with abiraterone.
Cecília M Alvim, André Mansinho, Rita S Paiva, Raquel Brás, Patrícia M Semedo

Future Sci OA· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis